A 4-aminonaphthalimide-based fluorescent traceable prodrug with excellent photoinduced cytotoxicity

A blue light activated anti-cancer prodrug, NST, was designed based on a photoactive 4-aminonaphthalimide derivative and an anticancer drug, 10-hydroxycamptothecin. NST was hard to be taken up by living cells and showed negligible dark cytotoxicity. The irradiation caused photocleavage of NST and resulted in high cytotoxicity.

Automated summary

NST is a blue light activated anti-cancer prodrug that shows minimal cytotoxicity in the dark but exhibits high cytotoxicity through photocleavage upon irradiation.